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Abstract 
microRNAs (miRNAs), small non-coding RNAs, play a critical role in differentiation 
and selfrenewal of pluripotent stem cells as well as in differentiation of cardiovascular 
lineage cells. Several miRNAs have been identified to repress stemness factors such 
as Oct4, Nanog, Sox2 and Klf4 in embryonic stem cells, thereby promoting 
embryonic stem cell (ESC) differentiation. Furthermore, targeting of different miRNAs 
promotes reprogramming towards induced pluripotent stem cells (iPSCs).   
miRNAs are critical for vascular smooth muscle cell (VSMC) differentiation and 
phenotype regulation, and miR-143 and miR-145 play a particularly important role in 
this respect. Notably, these miRNAs are downregulated in several cardiovascular 
disease states, such as in atherosclerotic lesions and vascular neointima formation. 
miRNAs are critical regulators of endothelial cell differentiation and ischemia-induced 
neovascularisation.  miR-126 is important for vascular integrity, endothelial cell 
proliferation and neovascularisation. miR-1 and miR-133 are highly expressed in 
cardiomyocytes and their precursors and regulate cardiomyogenesis. In addition, 
miR-499 promotes differentiation of cardiomyocyte progenitor cells.   
Notably, miRNA expression is altered in cardiovascular disease states, and recent 
studies suggest that dysregulated miRNAs may limit cardiovascular repair 
responses. Dysregulation of miRNAs may lead to an altered function and 
differentiation of cardiovascular progenitor cells, likely also representing a limitation 
of autologous cell-based treatment approaches in these patients.   
These findings suggest that targeting of specific miRNAs may represent an 
interesting novel opportunity to impact on endogenous cardiovascular repair 
responses, including effects on stem/progenitor cell differentiation and functions.  
This approach may also serve to optimize cell-based treatment approaches in 
patients with cardiovascular disease.  
 
This article is part of the Review Focus on: The Role of MicroRNA in Cardiovascular Biology 
and Disease 
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Introduction 
microRNAs (miRNAs) are small, non-coding RNAs regulating gene expression at the 
post-transcriptional level by mRNA degradation or translational repression.1 The 
human genome has been estimated to contain up to 1000 miRNAs.1 The regulation 
and processing of miRNAs is still incompletely understood, however, important 
progress has been made in unravelling of these pathways over the past several 
years.  In the first part of this review article we are summarizing some recent insights 
into the biogenesis and processing of miRNAs (see also Figure 1), that are also 
important for the discussion of studies evaluating the role of miRNAs in 
stem/progenitor cell differentiation and function. 
Notably, miRNAs have been identified to target transcription factors critically 
regulating embryonic stem cell self-renewal and differentiation.2-5 In addition, several 
miRNAs have been shown to facilitate reprogramming towards induced  pluripotent 
stem cells.6-10 Moreover, specific miRNAs have been identified to regulate 
differentiation and function of cardiac, vascular smooth muscle and endothelial 
progenitor cells, which are discussed in the present article. 
Furthermore, emerging data suggest that in cardiovascular disease altered miRNA 
expression may limit and impair cardiovascular repair responses, including 
differentiation and function of stem/progenitor cells.  Hence, understanding of the 
physiological and pathophysiological regulation and role of miRNAs in stem and 
progenitor cells will lead to an improved understanding of cardiovascular disease 
pathophysiology and likely provide interesting novel potential therapeutic targets to 
promote endogenous cardiovascular repair processes. 
 
miRNA biogenesis and processing 
Most miRNAs are located within introns, and are processed from the primary 
transcript of their host genes.11 This co-transcription of miRNAs is thought to aid in 
the fine-tuning of biological processes regulated by the host genes.12-14  miRNAs are 
mostly transcribed by RNA polymerase II,15 that generates the primary transcript with 
a stem-loop structure, called pri-miR (Figure 1).   
pri-miRs are further processed by the microprocessor, i.e. the complex of the nuclear 
RNase III protein Drosha and the associated co-factor DGCR8 (DiGeorge syndrome 
critical region 8), which releases a shorter hairpin of about 65 nucleotides (pre-miR) 
after cleavage.16, 17 Pre-miRs are transported via exportin-5 from the nucleus to the 
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cytoplasm,18 where they are cleaved by Dicer, a RNase III enzyme.19-23 One strand of 
the unwound miRNA helix is preferentially chosen and loaded into the RNA-induced 
silencing complex (RISC), whereas the other strand, miRNA*, is degraded.24, 25 In the 
RISC, miRNAs interact mainly with the 3’ untranslated regions (UTRs) of mRNAs, 
leading to mRNA destabilization or translational repression or both.26 Recent data 
suggest that in humans miRNAs largely lead to mRNA destabilization.27  Of note, 
more recently miRNAs have also been suggested to increase protein expression of 
some targets,28, 29 however, the underlying mechanisms need to be further 
determined. 
miRNA biogenesis may also differ from the above canonical stepwise processing 
pathway. For example, mirtrons are very short introns of genes that by splicing 
directly form pre-miRNAs and are therefore not processed by Drosha.30, 31 In 
addition, there are miRNAs that are processed independent of Dicer that require the 
Argonaute protein Ago2 for miRNA maturation.32, 33  
 
miRNAs regulate embryonic stem cell differentiation and self-renewal   
Dicer and DGCR8-knockout inhibit ESC differentiation:  The contribution of miRNAs 
to differentiation and function of embryonic stem cells (ESCs) has initially been 
elucidated using knockout models of parts of the miRNA-processing pathways, i.e. 
deletion of Dicer or the Drosha-cofactor DGCR8. Notably, Dicer-deficiency was lethal 
at an early stage of development in mouse embryos.34 In vitro, Dicer-null ESCs failed 
to differentiate and remained in a self-renewal state, indicating a critical role of 
miRNAs for ESC differentiation.35 Similarly, DGCR8-knockout ESCs failed to undergo 
cell lineage commitment, and had an incomplete silencing of the pluripotency factors 
Oct4, Sox2, Nanog and Rex1.36 These findings underscore the critical role of 
miRNAs for ESC differentiation into specific cell lineages (Figure 2). 
 
miRNAs regulating ESC self-renewal and differentiation:  Subsequently, several 
miRNAs have been observed to be preferentially expressed in embryonic stem cells.  
By sequencing short RNAs, the miRNA 290-295 cluster has been found to be highly 
expressed in embryonic stem cells.2 These miRNAs promote ESC proliferation by 
facilitating the G1-S transition in the cell cycle,37, 38 and are therefore considered to 
have a role in maintaining ESC pluripotency (Figure 2).  
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Several miRNAs have been identified to be part of the ESC differentiation process 
and repress multiple pluripotency factors involved in self-renewal of ESCs as 
described below. MiR-134, miR-296 and miR-470, which are upregulated in the 
differentiation of mouse embryonic stem cells, target the transcription factors Nanog, 
Sox2 and Oct4.4 miR-21 suppresses self-renewal of mouse ESCs, at least in part by 
decreasing expression of the pluripotency factors Oct4, Nanog, Sox2 and c-Myc.3 
miR-145 expression is low in self-renewing human ESCs and is highly upregulated 
during human ESC differentiation.  miR-145 directly targets the pluripotency factors 
Oct4, Sox2, and Klf4 and increased miR-145 expression inhibits ESC self-renewal, 
represses expression of the above pluripotency genes, and induces lineage-
restricted differentiation.5 
 
Targeting miRNAs to promote reprogramming towards induced pluripotent 
stem cells 
Mouse fibroblasts were the first differentiated somatic cells, which were 
reprogrammed into iPSCs by viral transduction of Oct3/4, Sox2, c-Myc, and Klf4.39 
Human fibroblasts could subsequently be converted into iPSCs by transduction of the 
same four transcription factors40 or by introduction of Oct4, Sox2, Nanog, and 
Lin28.41 As mentioned above, stemness factors are regulated by miRNAs, which 
renders them highly interesting for promoting nuclear reprogramming processes of 
somatic cells, given the advantage of a nonviral transfection procedure. The role of 
miRNAs in promoting reprogramming of iPSCs has therefore been intensely 
examined.42   
 
Enhancing transcription factor induced reprogramming towards iPSCs using 
miRNAs:  Notably, silencing of members of the let-7 miRNA family in murine somatic 
cells has been shown to promote reprogramming towards induced pluripotent stem 
cells (iPSCs).8 Introduction of miR-291-3p, miR-294 and miR-295 together with the 
transcription factors Oct4, Sox2 and Klf4 substantially enhanced the efficacy of 
reprogramming towards iPSCs.7 These miRNAs have been termed ES cell–specific 
cell cycle–regulating miRNAs (ESCC) because of their abundance and role in 
proliferation of mouse ESCs.37 Similar results have been reported using the human 
ESCC miRNA orthologs miR-302b and miR-372.10  
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Induction of reprogramming towards iPSCs using miRNAs without stemness factors:  
Recently, a non-transcription factor mediated methodology using miRNAs to reset 
mouse embryonic fibroblasts into a pluripotent state has been reported.6  By 
transducing the miR-302/367 cluster as well as the Hdac-inhibitor VPA into mouse 
embryonic fibroblasts an increased efficacy of iPSC formation was observed as 
compared to transduction using stemness factors (with VPA).6  
Moreover, it has been shown that it is possible to reprogram cells to pluripotency 
without viral transfection by direct transfection of mature miRNAs (miR-200c, miR-
302 s, and miR-369s family members) into adipose stromal cells (mASCs).9 
However, the efficacy of dedifferentiation was reduced as compared to the viral 
transfection procedures, especially in human dermal fibroblasts.9 
The above studies demonstrate that miRNAs are strongly involved in the regulation 
of pluripotency and differentiation of stem cells. Lineage commitment steps are 
frequently regulated by multiple miRNAs. Targeting miRNAs has therefore become 
an interesting novel approach to modulate stem cell differentiation.  A further refined 
understanding of these miRNA-regulated pathways will lead to novel tools to guide 
stem cell differentiation and function that is particularly important for regenerative 
medicine. Moreover, direct reprogramming of adult fibroblasts into induced 
cardiomyocytes has recently been reported,43 and it will be highly interesting to see 
whether this can also be enhanced or even achieved alone by targeting or 
introduction of miRNAs.    
 
miRNAs regulating vascular smooth muscle cell differentiation and phenotype  
VSMC specific knockout of Dicer reveals a critical role of miRNAs in VSMC 
differentiation: Recently, the role of miRNAs in differentiation and function of VSMCs 
has been elucidated by generating a VSMC-specific Dicer knockout mouse. Mutant 
mice died between embryonic day 16 and 17 due to extensive hemorrhage and a 
thinned wall of the aorta caused by a decreased proliferation of VSMCs.44 
Furthermore, a loss of contractile function and differentiation of VSMCs could be 
observed, whereas transfection with mimic miR-145 could partially rescue the 
impaired contractile function and differentiation of VSMCs.44  
 
miR-143 and miR-145 regulate VSMC differentiation and phenotype: MiR-143 and 
miR-145 are co-transcribed and are crucial for the VSMC cell fate, i.e. regulation of 
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differentiation, phenotype and function, of vascular smooth muscle cells (VSMC).29 
These miRNAs are co-transcribed and are controlled by Nkx2-5 (NK2 transcription 
factor related, locus 5) and the SRF (serum response factor) with its co-activator 
Myocardin. miR-143 promotes VSCM differentiation by repressing Elk-1,29 and 
thereby preventing Elk-1 dependent suppression of VSMC differentiation marker 
gene expression.45 The potent properties of miR-145 to promote VSMC 
differentiation were underlined by the observation that overexpression of miR-145 in 
neural crest stem cells resulted in differentiation towards VSMCs in vitro.29 VSMCs of 
mice lacking either miR-143, miR-145 or both are expressing a less differentiated 
phenotype of VSMCs, indicating that miR-143/145 modulate the fine-tuning of the 
plasticity of VSMCs.46 Consistently, a decrease of contractile VSMCs and an 
accumulation of synthetic VSMCs were found in the aorta and the thinned femoral 
artery in another study examining a miR-143/miR-145 knockout mouse model.47 
Moreover, agonist-mediated contractility in arterial rings and blood pressure in vivo 
were reduced in miR-143/145-knockout mice.47  
Inducible depletion of SMC-specific Dicer in adult mice led to a similar, although 
substantially more severe phenotype as observed in miR-143/135 knockout mice, 
suggesting that additional miRNAs are involved in maintaining postnatal VSMCs in a 
differentiated state.48   
 
miR-1 regulates VSMC differentiation: Recently, miR-1, which mediates cardiac 
muscle differentiation after activation of Myocardin, was shown to be involved in the 
differentiation process of VSMCs.49, 50 Overexpression of Myocardin in human 
VSMCs induces miR-1 and represses proliferation. This process can be reversed by 
inhibition of miR-1.49 Furthermore, ESC differentiation into VSMCs depends on miR-
1. miR-1 expression was increased during differentiation of ESCs into VSMCs, 
whereas inhibition of miR-1 represses VSMC differentiation.50 miR-1 shares an 
identical target with miR-145, the transcription factor Klf4.50  
 
miR-221 and miR-222 regulate VSMC phenotype: miR-221 and miR-222 target the 
cyclin-dependent kinase (CDK) inhibitors p27 and p57 in VSMCs and thereby 
promote cell cycle progression and proliferation of these cells.51, 52  Notably, 
knockdown of miR-221 and miR-222 suppressed VSMC proliferation in vivo and 
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neointimal lesion formation after carotid angioplasty,52, 53 and these miRNA may 
therefore provide a potential therapeutic target to suppress neointima formation.51, 52 
 
miRNAs regulate vascular integrity, endothelial cell proliferation and function  
Dicer knockdown reveals critical role of miRNAs in vascular development and 
endothelial cell functions: Several miRNAs have been identified to play an important 
role in vascular growth, endothelial cell differentiation, proliferation and functions.  
First attempts to gain insight into the role of miRNAs in vascular 
development/angiogenesis were made by engineering vertebrates lacking Dicer.20 
Dicer-deficiency resulted in lethality in early development.34, 53 Morphological analysis 
revealed less developed blood vessels in embryos and fewer blood vessels in yolk 
sacs, suggesting that compromised vessel formation/maintenance is leading to 
embryonic lethality.53 Consistent with this observation, mice with a hypomorphic 
Dicer expression are infertile owing to an impaired angiogenesis in the corpus 
luteum.54 Moreover, a reduction of endothelial miRNAs by Cre-dependent knockout 
of Dicer in ECs resulted in an impaired angiogenesis in distinct models of post-natal 
angiogenesis.55 
Subsequently, in vitro studies using Dicer-deficient endothelial cells (EC) were 
performed. Silencing of Dicer in endothelial cells caused an impairment of capillary 
sprouting, tube formation and migration capacity.56, 57 This was, at least in part, 
related to downregulation of pro-angiogenic miRNAs, i.e. let-7f and miR-27b, and a 
subsequently increased expression of several anti-angiogenic factors.57, 58  
 
miR-126 regulates vascular integrity, endothelial cell proliferation and 
neovascularisation:  The most abundant miRNA in CD31+ cells is miR-126.59 
Morpholino-induced knock-down of miR-126 in zebrafish caused compromised 
vascular integrity and led to hemorrhages.59 Similarly, defects in vascular 
maintenance were also shown in mice lacking miR-126.60 40% of miR-126 deficient 
mice died embryonically or perinatally due to defects in endothelial cell proliferation, 
migration, and angiogenesis causing leaky vessels and hemorrhages.60 The 
surviving subset of mutant mice had a markedly increased mortality and reduced 
infarct borderzone neovascularisation after myocardial infarction.60 In summary, miR-
126 is important for maintaining vessel integrity during embryogenesis. This was 
further highlighted in a study investigating aortic arch development in zebrafish, 
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where blood flow activated miR-126, which in turn enhanced vascular endothelial 
growth factor (VEGF) signaling, thereby facilitating angiogenic sprouting.61 However, 
miR-126 overexpression in ESCs failed to upregulate endothelial cell specific 
markers in vitro, hence it is not sufficient to induce endothelial lineage commitment in 
ESCs.59  
 
miR-17-92 cluster regulates neovascularisation: As first shown in several studies in 
the oncology field, the miR-17-92 cluster, which is induced by the transcription factor 
c-Myc, regulates distinct angiogenic functions.62, 63 miR-92a, a member of the miR-
17-92 cluster, exerts antiangiogenic functions.64 Antagomir-based silencing of miR-
92a increases infarct borderzone neovascularisation after myocardial infarction.64 
MiR-17, miR-18a, miR-19a, and miR-20a inhibit angiogenic activity of mature 
endothelial cells in vitro and knockdown of miR-17 and miR-20a increased vessel 
formation as observed in a matrigel plug assay in vivo.65 In contrast, miR-17-5p, miR-
18a, and miR-20a promote proliferation and cord formation in Dicer-deficient human 
ECs55 and enhance neovascularisation in tumor cells transduced with the miR-17-92 
cluster,66 indicating that the regulatory mechanisms of the miR-17-92 cluster differ in 
distinct tissues and are depending on the cellular context.  Therefore, the effect of 
miRNAs from the 17-92 cluster differs for ischemia-induced and tumor-associated 
angiogenesis, which is important if one considers these miRNAs as potential 
therapeutic targets.   
 
miRNAs and cardiomyocyte differentiation  
miR-1 and miR-133 control cardiomyocyte differentiation: miR-1 and miR-133 are 
highly expressed in cardiac and skeletal muscle cells and their precursors, belong to 
the same transcriptional unit and play a critical role in myogenesis.67-70 miR-1, 
consisting of 2 miRNA genes (miR-1-1 and miR-1-2) is co-transcribed with 2 (miR-
133a-2 and miR-133a-1) out of 3 existing miR-133 genes.67, 70 These miRNAs are 
induced by the muscle differentiation factors SRF, Mef2 and Myocardin.67, 71  
miR-1 (and to a lesser extent miR-133) promotes mesodermal progenitor formation 
and suppresses non-muscle gene expression in mouse and human ESCs.72 The 
miR-1 dependent adoption of a myogenic phenotype is supported by the repression 
of Hdac4, which negatively regulates Mef2, an essential transcription factor for the 
differentiation pathway of muscle cells.71, 73 Furthermore, miR-1 downregulates Notch 
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ligand Delta-like 1(DLL-1), which is involved in cardiomyocyte differentiation of ESCs 
and cardiac progenitor cell division.72 MiR-1 also modulates the fine-tuning of cell 
polarity.74 Fly embryos deficient for dmiR-1 had misaligned cardioblasts.74  
In vivo, deletion of dmiR-1, the single ortholog of miR-1 in Drosophila, is lethal due to 
a loss of muscle differentiation.68 miR 1-2 mutant mice revealed ventricle septum 
defects, cardiac hyperplasia and abnormal conduction.75 In this study, miR-1-1, the 
second member of the miR-1 family, could not compensate for the loss of its 
redundant miR 1-2.75 Overexpression of dmiR-1 decreased cardiac cell number68 and 
cardiac-specific excess of miR-1 in mice decreased proliferation by targeting Hand2, 
a transcription factor regulating ventricular cardiomyocyte expansion.67  
miR-133 plays a distinct role after mesodermal differentiation. In contrast to miR-1, 
miR-133 represses cardiac markers, promotes proliferation of myoblasts and inhibits 
differentiation through repression of SRF.72 Depletion of the miR-133 family resulted 
in defects of cardiac morphogenesis and increased proliferation of cardiomyocytes, 
whereas single depletion resulted in a normal phenotype.76   
 
miR-17-92 cluster regulates cardiac development: The miR-17-92 cluster contributes 
to regulation of heart development, as indicated by ventricular septal defects of the 
hearts in a loss-of-function model.77 Furthermore, miR-92 controls endoderm 
development.78 Overexpression of miR-92 in zebrafish results in a suppression of 
endoderm formation, which leads to cardia bifida.78  
 
miR-499 promotes cardiomyocyte differentiation: During cardiomyocyte differentiation 
of human cardiomyocyte progenitor cells (hCMPC),79  human cardiac stem cells 
(hCSC)80 and human ES cells,81 miR-499 is highly upregulated.  Overexpression of 
miR-499 in human cardiomyocyte progenitor cells indirectly promotes cardiac muscle 
differentiation by targeting sex determining region Y-box 6 (Sox6) and regulator of 
differentiation 1 (Rod1) in vitro.79, 80 Furthermore, overexpression of miR-499 in 
hESCs and hCMPCs upregulated cardiac marker expression, suggesting a role for 
miR-499 to control cardiomyocyte cell fate.79, 81 However, in adult mice cardiac miR-
499 overexpression resulted in cellular cardiac hypertrophy and cardiac 
dysfunction.82 
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miRNA alterations in human cardiovascular disease 
Dysregulated expression of miRNAs has been observed in human cardiovascular 
disease, including altered regulation in progenitor cells.83 miRNA tissue profiling 
approaches in cardiomyopathies84, and in progenitor cells85 revealed an altered 
regulation of miRNAs in different cardiovascular disease states. Subsequently, 
circulating human miRNA-expression profiles in plasma samples were investigated in 
distinct cardiovascular diseases such as stable coronary artery disease86 and 
essential hypertension87 as well as in patients with cardiovascular risk factors such 
as Diabetes mellitus.88, 89 
Recently, miRNAs have been implicated in the functional cardiovascular repair 
capacity of progenitor cells (Table 1).  Thus, differential miRNA regulation may play a 
role in cardiovascular disease by both, altering the repair potential of progenitor cells 
as well as by impacting on the function and phenotype of differentiated cells. Here we 
will discuss in particular miRNAs that may also play a role in progenitor cells. 
 
miRNA regulation in early endothelial progenitor cells in cardiovascular 
disease 
Early endothelial progenitor cells (EPCs) have been suggested to promote 
endothelial cell growth (largely in a paracrine manner) and may thereby promote 
endothelial repair responses and improve cardiac function. As described in detail 
below, several recent studies have described alterations in miRNAs in early EPCs 
derived from patients with cardiovascular disease, that may critically limit the 
endogenous repair response.  
 
miR-21 is increased in early EPCs in coronary artery disease:  In circulating early 
endothelial progenitor cells (EPCs), miR-21 has been reported to be upregulated 
after treatment with asymmetrical dimethylarginine (ADMA).85 miR-21 expression 
was increased in early EPCs from patients with coronary artery disease.85 Moreover, 
overexpression of miR-21 in early EPCs has been shown to inhibit their migratory 
capacity through repression of superoxide dismutase 2 (SOD2), a key protection 
protein against oxidative damage, and the endogenous mitogen-activated protein 
kinase inhibitor sprouty-2 (SPRY2).85 
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miR-221 and miR-222 are increased in early EPCs in coronary artery disease:  miR-
221/222 levels have been observed to be increased in early EPCs derived from 
patients with coronary artery disease (CAD) as compared to healthy subjects and 
were inversely correlated with EPC number in these patients.90 After treatment with 
Atorvastatin, miRNA-221/222 expression decreased and early EPC number 
increased in patients with CAD, but no causal relationship has been examined.90 
miR-221 and miR-222 are also expressed in VSMCs and ECs.  ECs overexpressing 
miR-222 showed a diminished proliferation and vessel formation in matrigel plugs.91 
In VSMCs, platelet-derived growth factor (PDGF), a major growth factor to promote 
neointima formation, induces miR-221/222 expression in vitro.52 Knockdown of miR-
221/222 decreases cell proliferation in cultured VSMCs as well as neointima 
formation in balloon-injured rat arteries.52 
 
miR-126 and miR-130a are reduced in early EPCs in chronic heart failure: Early 
EPCs from patients with chronic heart failure due to ischemic cardiomyopathy (ICM) 
showed a markedly reduced expression of miR-126 as compared to early EPCs from 
healthy subjects (HS), and the in vivo cardiac repair capacity of EPCs from healthy 
subjects was markedly reduced after anti-miR-126 transfection.92 Moreover, a 
reduced expression of miR-130a was observed in early EPCs from patients with 
chronic heart failure.92 This miRNA is known to promote angiogenesis by targeting 
the homeobox genes GAX and HOXA5 in ECs.93   
The role of miR-126 in ischemia-induced angiogenesis has been further shown by an 
antagomir-based silencing of miR-126 in a hindlimb ischemia model, in which 
capillary vessel formation was reduced.94 
 
miR-34a limits pro-angiogenic capacity of early EPCs:  miR-34a has been suggested 
as an antiangiogenic and proapoptotic miRNA expressed in early EPCs, and has 
been first shown to target silent information regulator 1 (Sirt1) in colorectal carcinoma 
cells.95 Sirt1 is a regulator of apoptosis, cell cycle and senescence and acts as a 
mediator of angiogenesis in ECs. Introduction of mimic miR-34a into rat early EPCs 
inhibited angiogenesis and induced senescence in vitro.96 This was suggested to be 
mediated by Sirt1-targeting and partially by upregulation of a downstream target of 
Sirt1, forkhead box O transcription factor 1 (FoxO1).96 
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miRNAs mediate preconditioning and regulate viability of stem/progenitor cells  
Recent studies, as described below, have explored the role of miRNAs in mediating 
preconditioning effects on stem/progenitor cells. These findings may provide 
interesting novel opportunities for optimization of cell-based treatment approaches for 
cardiac repair.   
 
miR-21 exerts cytoprotective effects in skeletal myoblasts: In skeletal myoblasts, 
miR-21 was upregulated after pharmacological preconditioning with Diazoxide.97 The 
observed cytoprotective effects (with respect to oxidative stress challenge) were 
reduced after anti-miR-21 treatment, suggesting a critical role of miR-21 in this 
process.97 miR-21 is also upregulated in left ventricles of rats after ischemic 
preconditioning in vivo and has been proposed to exert antiapoptotic effects through 
inhibition of programmed cell death 4 (PDCD4).98 
 
miR-146a protects MSCs from apoptosis: Preconditioning of mesenchymal stem cells 
(MSCs) with Diazoxide prevented these cells from apoptosis through a NF-κB-
dependent induction of miR-146a in vitro.99 Upregulation of miR-146a conducts 
cytoprotective effects by repression of Fas (CD 95), a TNF receptor family-member, 
which is required for cell death programming.99  
 
miR-155 may improve survival of cardiomyocyte progenitor cells: miR-155 is 
upregulated in human cardiomyocyte progenitor cells after exposure to hydrogen-
peroxide and has been suggested to improve their survival and inhibit necrosis 
through repression of receptor interacting protein 1 (RIP1), a death domain receptor-
associated protein.100  
 
miR-210 improves survival of transplanted MSCs in the heart: Ischemic 
preconditioning of mesenchymal stem cells (MSCs) upregulated miR-210 expression 
in a Hif-1α-dependent fashion and improved their survival after engraftment in the rat 
infarcted heart.101 This was mediated by targeting FLASH/caspase-8-associated 
protein-2, a pro-apoptotic regulator.101 
 
miRNA cocktail (miR-21, miR-24, miR-221) improves viability of transplanted cardiac 
progenitor cells: As miRNAs can improve the functional behavior of progenitor cells, 
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transfection with multiple miRNAs are an emerging approach in order to target the 
same deleterious transcript more efficiently or repressing multiple mRNAs in order to 
influence a pathophysiological process. In this respect, Hu et al. recently used a 
miRNA cocktail consisting of miR-21, miR-24 and miR-221 to transfect mouse 
cardiac progenitor cells, thereby showing that the viability of the transfected cells is 
enhanced after intramyocardial delivery, accompanied by an enhanced cardiac 
function after myocardial infarction.102  
 
Conclusions 
miRNAs have been identified as critical regulators of embryonic stem cell self-
renewal and differentiation. Several miRNAs have also been reported to promote 
iPSC reprogramming, which is particularly important for regenerative medicine.  
Specific miRNAs have been suggested to play a critical role in the differentiation of 
cardiovascular lineage cells, i.e. in vascular smooth muscle, endothelial cell and 
cardiomyocyte differentiation and function.   
Notably, miRNAs are differentially regulated in different cardiovascular diseases, 
including miRNAs expressed in stem/progenitor cells.  Altered expression profiles in 
circulating progenitor or resident tissue stem/progenitor cells may impair the 
endogenous cardiovascular repair capacity. As miRNA-targeted therapies are 
entering the clinical arena a detailed understanding of the role of miRNAs in 
stem/progenitor cell differentiation and functions as well as the alterations in 
cardiovascular disease is therefore required. A further understanding of the role of 
specific miRNAs in regulating or limiting endogenous cardiovascular repair 
responses involving stem/progenitor cells and cardiovascular lineage differentiation 
may lead to interesting novel therapeutic strategies to promote cardiovascular repair.   
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Figure legend 
 
Figure 1: Biogenesis of miRNA:  Schematic of the canonical pathway of miRNA 
transcription and processing.  miRNAs are transcribed mainly by RNA polymerase II 
leading to the primary transcript (pri-miRNA).  In the nucleus, pri-miRNAs are cleaved 
by the RNA-specific endoribonuclease Drosha (and its cofactor DGCR8) resulting in 
the pre-miRNA. Exportin-5 transports the pre-miRNA into the cytoplasm. In the 
cytoplasm pre-miRNAs are processed by Dicer leading to the miRNA-miRNA* 
duplex, where the miRNA is the active component and miRNA* gets degraded. In the 
RNA-induced silencing complex (RISC) the miRNA strand leads to mRNA 
destabilization or translational repression of mRNA. RISC, RNA-induced silencing 
complex; Ago1-4, Argonaute 1-4 
 
Figure 2:  Role of miRNAs in self-renewal and differentiation of pluripotent 
stem cells and in the differentiation of stem/progenitor cells into 
cardiovascular lineage cells.  Various miRNAs promote ESC differentiation, mostly 
by targeting stemness factors.  On the other hand, the miR-290-295 cluster inhibits 
ESC differentiation.  A subset of the miR-290-295 cluster (miR-291a-3p, miR-291b-
3p, miR-294 and miR-295) plus miR-302 are termed ES cell–specific cell cycle–
regulating miRNAs (ESCC) because they promote cell cycle progression in ESCs.  
These miRNAs have also been used to increase efficacy of iPSC formation. 
Furthermore, several miRNAs play an important role in cardiovascular cell lineage 
differentiation and the regulation of the phenotype of these cells. ESC, embryonic 
stem cell; iPSC, induced pluripotent stem cell; CM, cardiomyocyte; EC, endothelial 
cell; VSMC, vascular smooth muscle cell 
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Cell type 
Differentially 
expressed miRNA 
Disease/Modulator Targets  Function  ref. 
 
A: miRNA regulation in early endothelial progenitor cells  
 
Early endothelial progenitor cells  miR-21 CAD / ADMA SOD2; SPRY2 
Migration  
ROS formation 
85 
Early endothelial progenitor cells miR-221/222 CAD     Early EPC number 90 
Early endothelial progenitor cells miR-126 CHF Spred1   Angiogenesis 92 
Early endothelial progenitor cells miR-130a CHF HoxA5   Angiogenesis 92 
Early endothelial progenitor cells miR-34a 
miRNA-
overexpression 
Sirt1   
Senescence 
Angiogenesis 
96 
 
B: miRNAs mediating preconditioning and regulating viability of stem/progenitor cells 
 
Mesenchymal stem cells miR-210 IP Flash/Casp8ap2 Apoptosis   101 
Skeletal myoblast miR-21 PP (Diazoxide)     Apoptosis   97 
Mesenchymal stem cells miR-146a PP (Diazoxide) Fas (CD95) Apoptosis   99 
Cardiomyocyte progenitor cells miR-155 H2O2 RIP1   Necrosis   100 
Cardiac progenitor cells 
miR-21, miR-24, 
miR-221 (cocktail) 
miRNA-
overexpression 
Bim   Viability 102 
Table 1:  miRNAs differentially regulated in early endothelial progenitor cells (EPCs) or miRNAs mediating preconditioning and 
regulating viability of stem/progenitor cells 
CAD, coronary artery disease; ADMA, asymmetrical dimethylarginine; CHF, chronic heart failure; IP, ischemic preconditioning; PP, 
pharmacological preconditioning; SOD2, superoxide dismutase type II; SPRY2, Sprouty2; Spred1, Sprouty-related EVH-1 domain 
containing-1; Flash/Casp8ap2, FLICE-associated huge protein/caspase-8-associated protein-2; RIP1, receptor interacting protein 1; 
Sirt1, Silent information regulator 1; Bim: Bcl2l11 (Bcl-2 protein family) 
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